SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-291454
Filing Date
2015-08-14
Accepted
2015-08-14 13:36:16
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d27998d10q.htm 10-Q 173584
2 EX-4.1 d27998dex41.htm EX-4.1 26146
3 EX-10.1 d27998dex101.htm EX-10.1 20968
4 EX-31.1 d27998dex311.htm EX-31.1 7064
5 EX-31.2 d27998dex312.htm EX-31.2 7092
6 EX-32.1 d27998dex321.htm EX-32.1 6294
  Complete submission text file 0001193125-15-291454.txt   2290601

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT qhoi-20150630.xml EX-101.INS 158338
8 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20150630.xsd EX-101.SCH 59835
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20150630_cal.xml EX-101.CAL 33484
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20150630_def.xml EX-101.DEF 83957
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20150630_lab.xml EX-101.LAB 668306
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20150630_pre.xml EX-101.PRE 170643
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52062 | Film No.: 151054503
SIC: 2834 Pharmaceutical Preparations